What is CUSIP 03770Y107?

CUSIP 03770Y107 is the security identifier used in SEC filing datasets for APMD - Apnimed, Inc. - Common Stock, par value $0.00001 per share.

Who owns APMD - Apnimed, Inc. - Common Stock, par value $0.00001 per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Security Snapshot

Apnimed, Inc. - Common Stock, par value $0.00001 per share (APMD) Institutional Ownership

CUSIP: 03770Y107

13F Institutional Holders and Ownership History for Q3 2026

13F reference period

n/a

Institutions Reporting

Shares (Excl. Options)

n/a

Price

$18.22

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / Common Stock, par value $0.00001 per share
Symbol: APMD on Nasdaq
Shares outstanding: 41,603,056
SEC-reported price per share: $18.22

13F Shares, Excluding Options vs Price

13F Value, Excluding Options

Total Investors

Filing notes and source

Key facts

APMD - Apnimed, Inc. - Common Stock, par value $0.00001 per share is tracked under CUSIP 03770Y107.
13F reference-period holder data is not available.
3 significant owners is listed from Schedule 13D/13G reporting.

Change

Holder data for the Q2 2026 reference period is not available.
Available periods remain in the history table; they do not substitute for the headline period.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

03770Y107

13F reference period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

APMD full holder history Apnimed, Inc. SEC filings Apnimed, Inc. company facts Apnimed, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 03770Y107:

Q3 2026 (13 holders)

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows

Security

APMD

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
AMERIPRISE FINANCIAL INC	19%		7,476,992	Ameriprise Financial, Inc.	31 Jul 2026
SHIONOGI & CO LTD	7.1%	$53,818,546	2,953,817	SHIONOGI & CO LTD	30 Sep 2026
Tao Capital Management LP	5.2%		2,178,138	Tao Capital Management LP	31 Jul 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods

Headline period

n/a

Rows shown

1-1 of 1

Period	13F Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2026 Q3	1,616,991	$35,435,435	+$35,435,435			$21.91	13